Literature DB >> 17638851

Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells.

Lin Wang1, Heather O'Leary, James Fortney, Laura F Gibson.   

Abstract

Although leukemic stem cells (LSCs) show a symbiotic relationship with bone marrow microenvironmental niches, the mechanism by which the marrow microenvironment contributes to self-renewal and proliferation of LSCs remains elusive. In the present study, we identified a unique subpopulation of Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia (ALL) cells coexpressing markers of endothelial cells (including VE-cadherin, PECAM-1, and Flk-1) and committed B-lineage progenitors. After long-term coculture with bone marrow stromal cells, tumor cells formed hematopoietic colonies and cords, expressed early stem- cell markers, and showed endothelial sprouting. Gene expression profiles of LSCs were altered in the presence of stromal cell contact. Stromal cell contact promoted leukemic cell VE-cadherin expression, stabilized beta-catenin, and up-regulated Bcr-abl fusion gene expression. Our study indicates that these specific tumor cells are uniquely positioned to respond to microenvironment-derived self-renewing and proliferative cues. Ph(+)/VE-cadherin(+) tumor subpopulation circumvents the requirement of exogenous Wnt signaling for self-renewal through stromal cell support of leukemic cell VE-cadherin expression and up-regulated Bcr-abl tyrosine kinase activity. These data suggest that strategies targeting signals in the marrow microenvironment that amplify the Bcr-abl/VE-cadherin/beta-catenin axis may have utility in sensitizing drug-resistant leukemic stem cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638851      PMCID: PMC2200915          DOI: 10.1182/blood-2007-01-068122

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

Review 1.  The stem cell niches in bone.

Authors:  Tong Yin; Linheng Li
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

2.  Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation.

Authors:  Addolorata Maria Luce Coluccia; Angelo Vacca; Mireia Duñach; Luca Mologni; Sara Redaelli; Victor H Bustos; Daniela Benati; Lorenzo A Pinna; Carlo Gambacorti-Passerini
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

3.  A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia.

Authors:  C Cobaleda; N Gutiérrez-Cianca; J Pérez-Losada; T Flores; R García-Sanz; M González; I Sánchez-García
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

4.  Ubiquitination regulates PTEN nuclear import and tumor suppression.

Authors:  Lloyd C Trotman; Xinjiang Wang; Andrea Alimonti; Zhenbang Chen; Julie Teruya-Feldstein; Haijuan Yang; Nikola P Pavletich; Brett S Carver; Carlos Cordon-Cardo; Hediye Erdjument-Bromage; Paul Tempst; Sung-Gil Chi; Hyo-Jong Kim; Tom Misteli; Xuejun Jiang; Pier Paolo Pandolfi
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

5.  Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.

Authors:  M J Hendrix; E A Seftor; P S Meltzer; L M Gardner; A R Hess; D A Kirschmann; G C Schatteman; R E Seftor
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

6.  Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells.

Authors:  E Gunsilius; H C Duba; A L Petzer; C M Kähler; K Grünewald; G Stockhammer; C Gabl; S Dirnhofer; J Clausen; G Gastl
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

7.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block.

Authors:  Peggy Kirstetter; Kristina Anderson; Bo T Porse; Sten Eirik W Jacobsen; Claus Nerlov
Journal:  Nat Immunol       Date:  2006-09-03       Impact factor: 25.606

8.  p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.

Authors:  Jose Piedra; Susana Miravet; Julio Castaño; Héctor G Pálmer; Nora Heisterkamp; Antonio García de Herreros; Mireia Duñach
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.

Authors:  Yiguo Hu; Sarah Swerdlow; Theodore M Duffy; Roberto Weinmann; Francis Y Lee; Shaoguang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

Review 10.  Stem cells find their niche.

Authors:  A Spradling; D Drummond-Barbosa; T Kai
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

View more
  36 in total

1.  Anti-CHMP5 single chain variable fragment antibody retrovirus infection induces programmed cell death of AML leukemic cells in vitro.

Authors:  Hai-rong Wang; Zhen-yu Xiao; Miao Chen; Fei-long Wang; Jia Liu; Hua Zhong; Ji-hua Zhong; Ren-rong Ou-Yang; Yan-lin Shen; Shu-ming Pan
Journal:  Acta Pharmacol Sin       Date:  2012-05-21       Impact factor: 6.150

Review 2.  [Tumor stem cell research - basis and challenge for diagnosis and therapy].

Authors:  Heidrun Karlic; Harald Herrmann; Axel Schulenburg; Thomas W Grunt; Sylvia Laffer; Irina Mirkina; Rainer Hubmann; Medhat Shehata; Brigitte Marian; Edgar Selzer; Michael Pfeilstöcker; Elisabeth Pittermann; Ulrich Jäger; Hubert Pehamberger; Christoph Zielinski; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2010-07-22       Impact factor: 1.704

Review 3.  A hostel for the hostile: the bone marrow niche in hematologic neoplasms.

Authors:  Daniela S Krause; David T Scadden
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

4.  VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers.

Authors:  Stephen M Akers; Heather A O'Leary; Fred L Minnear; Michael D Craig; Jeffrey A Vos; James E Coad; Laura F Gibson
Journal:  Exp Hematol       Date:  2010-05-12       Impact factor: 3.084

5.  Bone Marrow Microenvironment Niche Regulates miR-221/222 in Acute Lymphoblastic Leukemia.

Authors:  Blake S Moses; Rebecca Evans; William L Slone; Debbie Piktel; Ivan Martinez; Michael D Craig; Laura F Gibson
Journal:  Mol Cancer Res       Date:  2016-06-29       Impact factor: 5.852

6.  Role of MSC-derived galectin 3 in the AML microenvironment.

Authors:  Peter P Ruvolo; Vivian R Ruvolo; Jared K Burks; YiHua Qiu; Rui-Yu Wang; Elizabeth J Shpall; Leonardo Mirandola; Numsen Hail; Zhihong Zeng; Teresa McQueen; Naval Daver; Sean M Post; Maurizio Chiriva-Internati; Steven M Kornblau; Michael Andreeff
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-04-12       Impact factor: 4.739

7.  VE-cadherin Regulates Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Sensitivity to Apoptosis.

Authors:  Heather O'Leary; Stephen M Akers; Debra Piktel; Cheryl Walton; James E Fortney; Karen H Martin; Michael Craig; James Coad; Laura F Gibson
Journal:  Cancer Microenviron       Date:  2010-03-02

8.  The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome.

Authors:  Selcuk Sozer; Maria Isabel Fiel; Thomas Schiano; Mingjiang Xu; John Mascarenhas; Ronald Hoffman
Journal:  Blood       Date:  2009-03-17       Impact factor: 22.113

9.  Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential.

Authors:  Ines Martin-Padura; Paola Marighetti; Giuliana Gregato; Alice Agliano; Omar Malazzi; Patrizia Mancuso; Giancarlo Pruneri; Andrea Viale; Francesco Bertolini
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

Review 10.  Cancer stem cells: controversies in multiple myeloma.

Authors:  Sarah K Brennan; William Matsui
Journal:  J Mol Med (Berl)       Date:  2009-09-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.